Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction

scientific article published on May 2016

Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JACC.2016.01.073
P698PubMed publication ID27126533

P50authorRon WaksmanQ7364511
P2093author name stringStephen E Epstein
Michael J Lipinski
Robert O Bonow
Edwin Wu
Dror Luger
Peter C Westman
P433issue17
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
P304page(s)2050-2060
P577publication date2016-05-01
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleInflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction
P478volume67

Reverse relations

cites work (P2860)
Q90069019Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction
Q90633309Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
Q42155507Associations between Left Ventricular Cavity Size and Cardiac Function and Overload Determined by Natriuretic Peptide Levels and a Covariance Structure Analysis.
Q92210566Biological Scaffolds for Abdominal Wall Repair: Future in Clinical Application?
Q64230003C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function
Q95277553Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
Q88523483Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions
Q93349471Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction
Q91512596Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock
Q50044861Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury
Q37695032Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance
Q89428892Depression and Anxiety in Heart Failure: A Review
Q58733328Effects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for AMI
Q100464550Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice
Q92233793Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice
Q90335075From Neutrophil Calcium Sensor to Myocardial Remodelling-A Double-Edged Pathway Guided by the Inflammasome
Q59805634Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
Q90161278Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled tr
Q91106624Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype
Q90683636IGF-1C domain-modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
Q50168083Immune mechanisms in heart failure
Q58793281Improvements in long standing cardiac pathologies by individualized homeopathic remedies: A case series
Q90667609Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
Q47734765Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
Q92524562Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure
Q64084650Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing
Q90153772Matrix metalloproteinase-12 produced by Ly6Clow macrophages prolongs the survival after myocardial infarction by preventing neutrophil influx
Q55230733Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.
Q39223572Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications
Q64974312Molecular Imaging of Inflammation in Ischemic Heart Disease.
Q92378330Molecular Imaging of the Heart
Q52619556Myocardial Infarction Remodeling that Progresses to Heart Failure: A Signaling Misunderstanding.
Q47902404Myocardial Infarction and Exercise Training: Evidence from Basic Science
Q91594685Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition
Q57177232Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?
Q36295418Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
Q50027785Persistent Inflammation, Stem Cell-Induced Systemic Anti-Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure
Q91988023Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure
Q38638181Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study.
Q92351043Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure
Q48138711Pre-revascularization coronary wedge pressure as marker of adverse long-term left ventricular remodelling in patients with acute ST-segment elevation myocardial infarction
Q98298303Regulatory T cells in ischemic cardiovascular injury and repair
Q51627539Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Q47682969Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Q91639887Salvia miltiorrhiza and Carthamus tinctorius Extract Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction by Epigenetically Inhibiting Smad3 Expression
Q46293355Sanggenon C protects against cardiomyocyte hypoxia injury by increasing autophagy
Q90341456Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure
Q30490730Statistical shape modeling of the left ventricle: myocardial infarct classification challenge
Q50125836Summed thickening score by myocardial perfusion imaging: A risk factor of left ventricular remodeling in patients with myocardial infarction
Q90652581The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure
Q41308721The Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection
Q45073088The NLRP3 inflammasome in acute myocardial infarction
Q47662772Trajectories of Circulating Monocyte Subsets After ST-Elevation Myocardial Infarction During Hospitalization: Latent Class Growth Modeling for High-Risk Patient Identification.
Q47677252Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.
Q90149907α1-AR overactivation induces cardiac inflammation through NLRP3 inflammasome activation

Search more.